Abstract
While the safety of the available live plague vaccine EV 76 (Paris) continues to be the subject of further study, the USP formol-killed, virulent Pasteurella pestis (Yersinia pestis) suspension capable of protecting 60% of non-human primates, particularly Hanuman langurs (Presbytis entellus), warrants further clinical tests and field trials. Inoculated in a dosage of 2×109 killed plague bacilli (1 ml), followed by a booster of 400 million organisms (0.2 ml) in 1-3 months, this vaccine stimulates the appearance of passive mouse-protection antibodies (below an index of 10) and passive haemagglutinins in 60%-65% of human subjects. Recent experiences in Viet-Nam demonstrate that personnel vaccinated with the USP vaccine, although frequently exposed, enjoy almost complete freedom from the disease. One of the 4 known and confirmed cases of bubonic plague in North Americans occurred in an unvaccinated individual. Among individuals inoculated with the USP vaccine, 2 confirmed cases of pneumonic plague and 1 case of asymptomatic pharyngeal plague have been recorded. The incidence of plague in the Republic of Viet-Nam during the past 3 years is estimated at 13 263 cases in a population in part vaccinated with a live plague which exhibited inadequate immunogenic efficacy in experimental tests.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BURROWS T. W. Virulence of Pasteurella pestis. Nature. 1957 Jun 15;179(4572):1246–1247. doi: 10.1038/1791246a0. [DOI] [PubMed] [Google Scholar]
- Cavanaugh D. C., Dangerfield H. G., Hunter D. H., Joy R. J., Marshall J. D., Jr, Quy D. V., Vivona S., Winter P. E. Some observations on the current plague outbreak in the Republic of Vietnam. Am J Public Health Nations Health. 1968 Apr;58(4):742–752. doi: 10.2105/ajph.58.4.742. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chen T. H., Meyer K. F. Susceptibility of the langur monkey (Semnopithecus entellus) to experimental plague: pathology and immunity. J Infect Dis. 1965 Dec;115(5):456–464. doi: 10.1093/infdis/115.5.456. [DOI] [PubMed] [Google Scholar]
- GIRARD G. L'IMMUNIT'E DANS L'INFECTION PESTEUSE. ACQUISITIONS APPORT'EES PAR 30 ANN'EES DE TRAVAUX SUR LA SOUCHE DE "PASTEURELLA PESTIS EV" (GIRARD ET ROBIC) Biol Med (Paris) 1963 Nov-Dec;52:631–731. [PubMed] [Google Scholar]
- Habbu M. K., Nimbkar Y. S., Jhala H. I. Selection of a suitable batch of plague vaccine for use as a standard. Indian J Pathol Bacteriol. 1968 Jul;11(3):152–159. [PubMed] [Google Scholar]
- KOROBKOVA E. I. Metody povysheniia effektivnosti zhivoi protivochumnoi vaktsiny EV. Zh Mikrobiol Epidemiol Immunobiol. 1955 Nov;(11):15–21. [PubMed] [Google Scholar]
- MEYER K. F. Recent studies on the immunity response to administration of different plague vaccines. Bull World Health Organ. 1953;9(5):619–636. [PMC free article] [PubMed] [Google Scholar]
- SPIVACK M. L., FOSTER L., LARSON A., CHEN T. H., BAKER E. E., MEYER K. F. The immune response of the guinea pig to the antigens of Pasteurella pestis. J Immunol. 1958 Feb;80(2):132–141. [PubMed] [Google Scholar]
- Smith H., Packman L. P. A filtered non-toxic plague vaccine which protects guinea-pigs and mice. Br J Exp Pathol. 1966 Feb;47(1):25–34. [PMC free article] [PubMed] [Google Scholar]
- WALKER R. V. Studies on the immune response of guinea pigs to the envelope substance of Pasteurella pestis. II. Fluorescent antibody studies of cellular and tissue response in mice and guinea pigs to large doses of fraction I. J Immunol. 1962 Feb;88:164–173. [PubMed] [Google Scholar]
- Walker R. V. Comparative physiopathology of plague endotoxin in mice, guinea pigs and monkeys. J Infect Dis. 1968 Apr;118(2):188–196. doi: 10.1093/infdis/118.2.188. [DOI] [PubMed] [Google Scholar]
- Walker R. V. Plague toxins. A critical review. Curr Top Microbiol Immunol. 1967;41:23–42. doi: 10.1007/978-3-642-46062-3_2. [DOI] [PubMed] [Google Scholar]